Literature DB >> 31038282

Hydroxyurea for children with sickle cell anemia: Prescribe it early and often.

Russell E Ware1,2,3, Patrick T McGann1,2,3, Charles T Quinn1,3.   

Abstract

Entities:  

Year:  2019        PMID： 31038282     DOI： 10.1002/pbc.27778

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  4 in total

Review 1.  Evidence-Based Minireview: In young children with severe sickle cell disease, do the benefits of HLA-identical sibling donor HCT outweigh the risks?

Authors:  Niketa Shah; Lakshmanan Krishnamurti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy.

Authors:  Tolulope O Rosanwo; Daniel E Bauer
Journal:  Mol Ther       Date:  2021-10-08       Impact factor: 11.454

3.  Hydroxyurea Use After Transitions of Care Among Young Adults With Sickle Cell Disease and Tennessee Medicaid Insurance.

Authors:  Joacy G Mathias; Vikki G Nolan; Lisa M Klesges; Sherif M Badawy; William O Cooper; Jane S Hankins; Matthew P Smeltzer
Journal:  JAMA Netw Open       Date:  2021-10-01

4.  The Relationship between Health Disparities, Psychosocial Functioning and Health Outcomes in Pediatric Hematology-Oncology and Stem Cell Transplant Populations: Recommendations for Clinical Care.

Authors:  Evrosina I Isaac; Andrea R Meisman; Kirstin Drucker; Stephanie Violante; Kathryn L Behrhorst; Alfonso Floyd; Jennifer M Rohan
Journal:  Int J Environ Res Public Health       Date:  2020-03-26       Impact factor: 3.390
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.